…o vascular and infectious complications, with frequent need for intravenous therapy and specialized immunosuppressive treatment. Early recognition …
All extracted treatments
Showing 841–900 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Articles mentioning treatments
7,227 articles · page 172 of 603…parameters.Conclusions Few trials have examined the efficacy of immunosuppressive drugs in lcSSc. Further research including lcSSc patients is needed t…
…stionnaire: 6 (0-21), MDHAQ: 0.6 (0.3-1.1) and PHQ-9 :5 (3-11); c-DMARDs was used in 64 (86%) patients being mycophenolate mofetil the m…
… self-reporting anxiety or depression (any severity) within the EQ-5D-5L domain was 60% in Europe, 32% in Japan, and 34% in the US. In t…
…roven efficacy to alleviate symptoms or improve quality of life.Early palliative care is recommended standard of care for incurable cancer as it impr…
… involvement was 10.6 YO. 92% of the patients were treated with DMARDs at time point 0 and 97% at time point 12 months. There was a si…
…y continued to progress despite improved nail care and stopping PUVA. The presence of oil spots, distal nail dystrophy and nail pitt…
…ystemic sclerosis (SSc) is associated with increased mortality. Intensive therapies have emerged for severe or refractory cases, but carry signific…
…lcers, interstitial lung disease and esophageal dysmotility, on vasoactive and immunosuppressive therapy, presented with tinnitus and holocranial gravitational headache…
…of scleroderma renal crisis (SRC) patients, evaluate the use of immunosuppressive therapies, and assess the association between these treatments and patien…
…e to any immunosuppressants at baseline until the initiation of immunosuppressive therapy, lung surgery, transplantation, or death. Trajectory was modele…
…laboration in achieving optimized and sustainable management of ART.Abstract P35 Figure 1–2 and Table 1…